If the committee advises the minister to delist the therapies on cost grounds, Health Minister Mark Butler still retains the power to set aside the advice and waive the reduction. Under the National Health Act 1953, the minister retains absolute discretion over pricing. …
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News -
Significant day marked by negotiation trigger and wholesaler remuneration changes
July 1, 2026 - - Latest News -
Protection gap leaves older Australians vulnerable this winter
July 1, 2026 - - Latest News -
Pharmacy Guild rejects AMA alarm over broader prescribing powers
July 1, 2026 - - Latest News -
Governments backs inhaled RNA therapy with the potential to change the future of chronic lung disease treatment
July 1, 2026 - -
Major new survey shows patients paying more and waiting longer for medicines
July 1, 2026 - - Latest News